CSRC plans to exempt foreign investors from short-term profit rules; Foshan Government vastly increases financial support for overseas IP protection; BNP Paribas gains regulatory approval from CBIRC for wealth management joint venture with Agricultural Bank of China.
In the first part of a two-part series, Ivan Jin, Allen Liu, Bella Cao and Huppert Hu of Merits & Tree Law Offices explain how foreign capital and Chinese insurance funds can aim to "dance with harmony" in China's private equity market, as they navigate multiple regulatory and practical challenges
As the relationship between the U.S. and China has deteriorated, an increasing number of Chinese companies are ending their U.S.-based operations. Derek Liu, Rod Hunter and Howard Wu of Baker McKenzie set out some guidance for those heading down that path
The U.S. Department of Defense imposes further sanctions on Chinese tech firms; Chinese chip companies denied access to U.S. technologies; Tim Hortons China secures a SPAC merger.
Insurance companies are allowed to issue open-ended capital bonds
EU targets modern slavery; Chinese companies raise more funds from SIX than NYSE; and Beijing seeks to retain foreign trade and investment
Four Chinese companies have listed on the Swiss Exchange in recent months and a host of law firms have benefited. More such IPOs are in the pipeline, but will interest in European listings last?
The U.S. is expected to formalize a ban on semiconductor export to China; Greater use of concealment techniques in securities fraud cases; ByteDance
Shanghai issues rules to clarify appraisal of SOE-invested PE fund units.
Lawyers also say U.S.-China trade tensions could be further damaged by "reverse CFIUS," a proposed law under which the U.S. government could prohibit investments into China it deems a threat to certain domestic capabilities.
